Table 4. Correlation between clinicopathologic data and P63 expression in the Kazakh ESCC.
| Clinicopathologic Parameter | No. of Cases | Expression of P63 |
X2 | P | |
|---|---|---|---|---|---|
| Positive n (%) | Negative n (%) | ||||
| Age (y) | |||||
| ≤Median (60y) | 45 | 39(86.7%) | 6(13.3%) | ||
| >Median | 40 | 32(80.0%) | 8(20.0%) | 0.739 | 0.691 |
| Gender | |||||
| M | 56 | 48(85.7%) | 8(14.3%) | ||
| F | 29 | 23(79.3%) | 6(20.7%) | 0.653 | 0.721 |
| Histologic grade | |||||
| Well | 17 | 15(88.2%) | 2(11.8%) | ||
| Moderate | 56 | 47(83.9%) | 9(16.1%) | 0.189 | 0.664 |
| poor | 12 | 5(41.7%) | 7(58.3%) | 7.128 | 0.008* |
| Nodal status | |||||
| pN+ | 41 | 35(85.3%) | 6(14.7%) | ||
| PN− | 44 | 37(84.1%) | 7(15.9%) | 0.055 | 0.973 |
| TNM stage | |||||
| I–II | 62 | 53(85.5%) | 9(14.5%) | ||
| III–IV | 23 | 19(82.6%) | 4(17.4%) | 0.107 | 0.948 |
*P < 0.05.